Blood Pressure and Arteries STUDIES

Highlights Randomized, double-blind, placebo-controlled, cross-over trial with 22 healthy adults Supplementation consists of single doses of 99% pure trans-resveratrol (250 mg or 500 mg) Resveratrol increases cerebral blood flow during cognitive performance, compared to...

Highlights Randomized, double-blind, placebo-controlled, cross-over trial with 28 obese, but otherwise healthy adults. Supplementation consists of resVida® resveratrol (75 mg/day for 6 weeks) Compared to placebo, resVida® significantly improves flow-mediated...

Highlights Randomized, double-blind, placebo-controlled trial with 36 dementia-free adults with type 2 diabetes Supplementation consists of single doses of resVida® (75, 150, and 300mg) at weekly intervals Compared to placebo,...

Highlights Randomized, open-label, controlled study 50 patients with primary acute myocardial infarction PepZinGI® significantly reduces biomarkers of inflammation vs. control PepZinGI® significantly increases ejection fraction vs. control Effective dosage is 75...

Highlights Pantesin® pantethine lowers risk markers in men and women with low or moderate CVD risk. Effective dosage is 600 mg/day (weeks 1 to 8), then 900 mg/day (weeks 9...